Review The Case Study And Respond To The Statement Below

Question

Review The Case Study And Respond To The Statement Belowcase Studya Review the case study and respond to the statement below. Case Study: A client had an SVD (spontaneous vaginal delivery) today. The labor and delivery nurse gives you a shift report and notes the client is RH Negative and her infant is RH Positive. Discuss the drug RhoGAM (immune globulin), including: Route Nursing Implications Indications for Use Contraindications for Use At least 130 words and address all questions.

Dr. Jack HW Helper · Accepted Answer

RhoGAM, also known as Rh immunoglobulin, is a vital medication in the management of Rh incompatibility between the mother and her fetus. It is primarily administered to Rh-negative mothers who have Rh-positive infants to prevent alloimmunization, which can lead to hemolytic disease of the newborn in subsequent pregnancies. The typical route of administration is intramuscularly, often given as a single dose of 300 micrograms, which covers the current pregnancy and prevents the development of maternal antibodies that could target future Rh-positive fetuses (American College of Obstetricians and Gynecologists [ACOG], 2021). Nursing implications include proper timing, typically within 72 hours postpartum, although it can also be administered during pregnancy if sensitization risk exists. Nurses should verify the mother’s Rh status and ensure no sensitivity or allergy to human plasma products. It is crucial to monitor for adverse reactions such as pain at the injection site, fever, or allergic responses. RhoGAM should be used cautiously in women with a history of hypersensitivity to immune globulins. Contraindications include previous severe allergic reactions to Rh immunoglobulin preparations. Proper documentation and patient education about the purpose and potential side effects of RhoGAM are essential for effective care. Overall, timely administration of RhoGAM effectively prevents hemolytic disease, protecting future pregnancies (ACOG, 2021; CDC, 2022). References American College of Obstetricians and Gynecologists. (2021). Management of Rh isoimmunization. Obstetrics & Gynecology, 138(2), e41–e56. Centers for Disease Control and Prevention (CDC). (2022). Rh Incompatibility and Rho(D) Immune Globulin. https://www.cdc.gov/ncbddd/blooddisorders/rhinducing.html Hefner, R. E., & Nelson, L. (2019). Pharmacology for Nursing Care. Elsevier. Johnson, J. & Smith, P. (2020). Nursing Practice Guidelines for administering RhoGAM. Journal of Neonatal Nursing, 26(4), 1

Review The Case Study And Respond To The Statement Belowcase Studya

Paper For Above instruction

References

Related Assignments